The BRU has been awarded an MRC-NIHR National Phenome Centre pilot project, which will facilitate new and exciting research into identifying biomarkers that could predict RA patients' response to MTX.
The aim of the internal Peer Review is to enhance the competitiveness of RfPB applications from MAHSC members, improving quality by providing critical evaluations of applications in final draft stage.
Manchester Molecular Pathology Innovation Centre, to be led by Professor Tony Freemont, BRU Theme Lead , will employ and train scientists in the usof emerging molecular pathology research techniques.
The Greater Manchester Clinical Research Awards provide an opportunity for people working in the Greater Manchester research community to benchmark their skills against their peers.
Free of charge event, hosted by Prof. Paulo Stanga of Manchester Royal Eye Hospital, promises a fabulous line up of speakers, covering all the latest developments in Retinitis pigmentosa research